Federal State Institution “State Institute of Drugs and Good Practises” of the Ministry of Industry and Trade of Russian Federation is a unitary, non-commercial, research and medical institution.

«GILS and NP» is a Russian center of competence in the sphere of Good Manufacturing Practices (GMP).

The Institution is authorized to conduct medical products’ producer inspection on their correspondence to the rules of Good Manufacturing Practices (GMP). Institute employees are members of the unified GMP-inspectorate, approves by the Command of the Ministry of Industry and Trade of Russian Federation.

At «GILS and NP» there is an Educational center which implements educational programs of additional vocational education, vocational training and skill enhancement for pharmaceutical industry employees. Those include all the good Manufacturing practices.

There is also a GEP Centre, the aim of which is to execute support for enterprises in the sphere of good engineering practices.

The Head of the Institution is Vladislav Shestakov.

Additional information can be found on the Institute’s website:

The Ministry of Industry and Trade of the Russian Federation (Minpromtorg of Russia) is the federal executive body of Russia, which is implementing the functions of elaborating State policy legal regulation in the industrial and defense-industrial complex, as well as in the development of aviation technology, technical regulation and ensuring unity measurements, as well as the functions of the authorized federal executive body exercising state regulation of foreign trade activity.

Minpromtorg of Russia is the authorized body of the Russian Federation: to coordinate activities in the sphere of the medicinal products circulation in the part of their production; on the presentation to the EEC the information on pharmaceutical inspectors for the formation of the pharmaceutical inspectors register of the EAEU Member States.

The Ministry is responsible for maintaining a database on issued, revoked certificates of pharmaceutical manufacturers compliance with GMP rules; initiates the conduct of pharmaceutical manufacturers inspections on compliance with GMP rules; is responsible for issuing, suspending or terminating the certificates of pharmaceutical manufacturers compliance with the requirements of the GMP EAEU rules.

It was established on May 12, 2008.

Additional information can be found on website: